Roselabs Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2026 ,inter alia, to consider and approve Unaudited Financial Results Alongwith Limited Review Report Of The Company For The Quarter and Half Year ended September 30, 2026

ROSELABS FINANCE LIMITED October 14, 2026 The Listing Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, 400001 Scrip Code: 531324 Sub: Intimation of Board Meeting Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir(s), Pursuant to Regulation 29 of the SEBI Listing Regulations, 2015, we write to inform you that, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, October 22, 2026, inter-alia, to consider and to approve the Un-audited Financial Results alongwith Limited Review Report of the Company for the quarter and half year ended September 30, 2026. As we have informed through our letter dated September 28, 2026 and in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the trading window for dealing in shares of the Company has been closed for all designated persons with effect from October 1, 2026 upto 48 hours after the declaration of financial results by the Company. This intimation is also being uploaded on the Company’s website at www.roselabsfinancelimited.in Kindly take the same on record. Yours truly, For Roselabs Finance Limited Gunjan Taunk Company Secretary & Compliance Officer Membership No. A23346 Regd. Off.: 412, Floor-4, 17G Vardhaman Chamber, Cawasji Patel Road, Horniman Circle, Fort, Mumbai-400001 Tel.: +91.22.67737373 Website: www.roselabsfinancelimited.in, E-mail: roselabsfinance@lodhagroup.com CIN: L70100MH1995PLC318333